Search - tctmd.com

Displaying 21 - 40 of 67

Sort: Relevancy | Date

Presentation TCT 2025

TCT 597: Comparison of Incidence, Severity and Treatment of Silent Gastroesophageal (GE) Lesions Related to Transesophageal Echocardiography (TEE) Following Mitral vs. Tricuspid Transcatheter Edge-to-Edge Repair (M-TEER vs. T-TEER)

Presenter: Wolfgang Gerhard Bocksch

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2025

The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next?

Presenter: Partho P. Sengupta

October 26, 2025

Presentation TCT 2025

Noise to Knowledge: Accelerating Detection of Valvular Heart Disease with Stethophone AI-Phonoscopy.

Presenter: Mark Attila Opauszky

October 26, 2025

Presentation TCT 2025

Earlier Detection of Valvular Heart Disease

Presenter: Pierre Elias

October 26, 2025

Presentation TCT 2025

TCT 857: National Trends in Nonrheumatic Valvular Heart Disease Mortality Before and After the COVID-19 Pandemic in the United States

Presenter: Hasan Munshi

October 25, 2025

Podcast Heart Valve Matters

Medical Management of Valvular Heart Disease

October 09, 2025

Podcast Heart Valve Matters

The Undertreatment of Valvular Heart Disease

September 25, 2025

News Daily News

People With Tricuspid Valve Disease Want More Information, Sooner

Yael L. Maxwell

July 17, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Presentation NY Valves 2025

Case 4: Torrential TR in Severe HF with Shock (optimal timing for intervention)

Presenter: Mahesh V. Madhavan

June 27, 2025

Presentation NY Valves 2025

Case 3: MAC with Moderate-Severe MS/MR and Pulmonary Edema in an Elderly Patient

Presenter: Kashish Goel

June 27, 2025

Presentation NY Valves 2025

The Prognostic Value of Right Ventricular-Pulmonary Artery Coupling in Heart Valve Interventions: A Systematic Review and Meta-Analysis

Presenter: Vitaliy Androshchuk

June 27, 2025

Presentation NY Valves 2025

Case 2: Flail MV with Shock in a Non-operative Patient

Presenter: David G. Rizik

June 27, 2025

Presentation NY Valves 2025

Case 1: Severe Aortic Stenosis Presenting with Acute Shock

Presenter: Mark Bieniarz

June 27, 2025

Presentation NY Valves 2025

Trends and Outcomes After Routine Oral Anti-Coagulation in Valvular Heart Surgery in Patients Without Atrial Fibrillation

Presenter: Derrick Tam

June 27, 2025

Presentation NY Valves 2025

Treatment Algorithms for Acute Decompensated Valvular Heart Disease

Presenter: Jörg Hausleiter

June 27, 2025

News Daily News

AI-Informed Echo Can Aid Diagnosis, With High Accuracy

Caitlin E. Cox

June 26, 2025

Presentation NY Valves 2025

Case 4: Triple Valve Disease — Optimal Therapy Timing, Role of Surgery, and Staged Approaches

Presenter: Aakriti Gupta

June 26, 2025

Presentation NY Valves 2025

Case 3: Concomitant MR and TR — Staged, Hybrid, Robotic, and Medical Therapy Options

Presenter: Parasuram Krishnamoorthy

June 26, 2025

Advertisement

TCT 597: Comparison of Incidence, Severity and Treatment of Silent Gastroesophageal (GE) Lesions Related to Transesophageal Echocardiography (TEE) Following Mitral vs. Tricuspid Transcatheter Edge-to-Edge Repair (M-TEER vs. T-TEER)

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next?

Noise to Knowledge: Accelerating Detection of Valvular Heart Disease with Stethophone AI-Phonoscopy.

Earlier Detection of Valvular Heart Disease

TCT 857: National Trends in Nonrheumatic Valvular Heart Disease Mortality Before and After the COVID-19 Pandemic in the United States

Medical Management of Valvular Heart Disease

The Undertreatment of Valvular Heart Disease

People With Tricuspid Valve Disease Want More Information, Sooner

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Case 4: Torrential TR in Severe HF with Shock (optimal timing for intervention)

Case 3: MAC with Moderate-Severe MS/MR and Pulmonary Edema in an Elderly Patient

The Prognostic Value of Right Ventricular-Pulmonary Artery Coupling in Heart Valve Interventions: A Systematic Review and Meta-Analysis

Case 2: Flail MV with Shock in a Non-operative Patient

Case 1: Severe Aortic Stenosis Presenting with Acute Shock

Trends and Outcomes After Routine Oral Anti-Coagulation in Valvular Heart Surgery in Patients Without Atrial Fibrillation

Treatment Algorithms for Acute Decompensated Valvular Heart Disease

AI-Informed Echo Can Aid Diagnosis, With High Accuracy

Case 4: Triple Valve Disease — Optimal Therapy Timing, Role of Surgery, and Staged Approaches

Case 3: Concomitant MR and TR — Staged, Hybrid, Robotic, and Medical Therapy Options

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content